New drugs cure SmithKline's Tagamet blues

SmithKline Beecham said yesterday it had overcome last year's expiry of the protective patent on Tagamet, which was the best-selling ulcer drug, mainly through sales of new pharmaceuticals.

While sales of Tagamet fell by £200m in 1994, turnover from new drugs, led by the Paxil/ Seroxat anti-depressant, climbed 74 per cent to £810m.

This performance, coupled with acquisitions, helped SmithKline to beat most analysts' forecasts with a rise in underlying pre-tax profits from £1.22bn to £1.271bn for 1994. The shares - already buoyed by US clearance to market Havrix, the world's first hepatitis A vaccine - gained 18p to 497p.

Steve Plagg, analyst at NatWest Markets, said total sales of £6.49bn, up from £6.16bn, were in line with expectations, but trading profits, up from £1.08bn to £1.24bn, came in stronger than forecast.

"The latter can be attributed to stronger than expected performance in hepatitis B vaccine Energix-B and Clinical Laboratories. We continue to advise our clients to be fully weighted in the stock," he said.

Analysts were also heartened by the US clearance for Havrix, which was launched in the UK two years ago and is now on sale in 35 countries.

Stated taxable profits were £691m, depressed by £580m of restructuring charges. The one-off cost, which had been expected and should be paid back in three years, follows the purchase of Sterling and comprised £243m for reorganising the supply chain, £320m for integrating the business, and £17m for integrating research and development.

Jan Leschly, chief executive of SmithKline, which is raising the fourth interim dividend from 3.3p to 3.9p, said: "Our financial objectives were accomplished in large measure through growing sales of new products." Earnings per share, excluding exceptional costs, were 8.7p, up from 8.5p.

Paxil, known as Seroxat outside the US, saw worldwide sales advance 124 per cent to £333m. This, and buoyant sales of the Relafen arthritis medicine and the Kytril anti-nausea drug helped pharmaceutical sales in the US to rise by 7 per cent.

Excluding Tagamet, sales in the US grew by 17 per cent. "We are very pleased with what is happening in pharmaceuticals," said Mr Leschly.

Start your day with The Independent, sign up for daily news emails
PROMOTED VIDEO
News
i100
News
One father who couldn't get One Direction tickets for his daughters phoned in a fake bomb threat and served eight months in a federal prison
people... (and one very unlucky giraffe)
Arts and Entertainment
Sink the Pink's 2013 New Year's Eve party
musicFour of Britain's top DJs give their verdict on how to party into 2015
ebooks
ebooksA year of political gossip, levity and intrigue from the sharpest pen in Westminster
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Selby Jennings: VP/SVP Credit Quant- NY- Investment Bank

Not specified: Selby Jennings: VP/SVP Credit Quant Top tier investment bank i...

Selby Jennings: Quantitative Research | Equity | New York

Not specified: Selby Jennings: Quantitative Research | Global Equity | New Yor...

Selby Jennings: SVP Model Validation

Not specified: Selby Jennings: SVP Model Validation This top tiered investment...

Selby Jennings: Oil Operations

Highly Competitive: Selby Jennings: Our client, a leading European Oil trading...

Day In a Page

Aren’t you glad you didn’t say that? The worst wince-and-look-away quotes of the year

Aren’t you glad you didn’t say that?

The worst wince-and-look-away quotes of the year
Hollande's vanity project is on a high-speed track to the middle of nowhere

Vanity project on a high-speed track to nowhere

France’s TGV network has become mired in controversy
Sports Quiz of the Year

Sports Quiz of the Year

So, how closely were you paying attention during 2014?
Alexander Armstrong on insulting Mary Berry, his love of 'Bargain Hunt', and life as a llama farmer

Alexander Armstrong on insulting Mary Berry and his love of 'Bargain Hunt'

From Armstrong and Miller to Pointless
Sanchez helps Gunners hold on after Giroud's moment of madness

Sanchez helps Gunners hold on

Olivier Giroud's moment of madness nearly costs them
A Christmas without hope: Fears grow in Gaza that the conflict with Israel will soon reignite

Christmas without hope

Gaza fears grow that conflict with Israel will soon reignite
After 150 years, you can finally visit the grisliest museum in the country

The 'Black Museum'

After 150 years, you can finally visit Britain's grisliest museum
No ho-ho-hos with Nick Frost's badass Santa

No ho-ho-hos with Nick Frost's badass Santa

Doctor Who Christmas Special TV review
Chilly Christmas: Swimmers take festive dip for charity

Chilly Christmas

Swimmers dive into freezing British waters for charity
Veterans' hostel 'overwhelmed by kindness' for festive dinner

Homeless Veterans appeal

In 2010, Sgt Gary Jamieson stepped on an IED in Afghanistan and lost his legs and an arm. He reveals what, and who, helped him to make a remarkable recovery
Isis in Iraq: Yazidi girls killing themselves to escape rape and imprisonment by militants

'Jilan killed herself in the bathroom. She cut her wrists and hanged herself'

Yazidi girls killing themselves to escape rape and imprisonment
Ed Balls interview: 'If I think about the deficit when I'm playing the piano, it all goes wrong'

Ed Balls interview

'If I think about the deficit when I'm playing the piano, it all goes wrong'
He's behind you, dude!

US stars in UK panto

From David Hasselhoff to Jerry Hall
Grace Dent's Christmas Quiz: What are you – a festive curmudgeon or top of the tree?

Grace Dent's Christmas Quiz

What are you – a festive curmudgeon or top of the tree?
Nasa planning to build cloud cities in airships above Venus

Nasa planning to build cloud cities in airships above Venus

Planet’s surface is inhospitable to humans but 30 miles above it is almost perfect